Cardioprotection with Yet Another SGLT2 Inhibitor - An Embarrassment of Riches.

Brosius, Frank C; Vandvik, Per O

Brosius, Frank C; Vandvik, Per O.

Brosius FC; From the Department of Medicine, University of Arizona, Tucson (F.C.B.); the Department of Internal Medicine, University of Michigan, Ann Arbor (F.C.B.); and the Institute of Health and Society, University of Oslo, and the Department of Medicine, Lovisenberg Diaconal Hospital, Oslo (P.O.V.).
Vandvik PO; From the Department of Medicine, University of Arizona, Tucson (F.C.B.); the Department of Internal Medicine, University of Michigan, Ann Arbor (F.C.B.); and the Institute of Health and Society, University of Oslo, and the Department of Medicine, Lovisenberg Diaconal Hospital, Oslo (P.O.V.).

N Engl J Med ; 384(2): 179-181, 2021 01 14.

Article in English | MEDLINE | ID: covidwho-1030312

Subject(s)

Diabetes Mellitus; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Embarrassment; Glycosides; Humans; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google